SMS Pharmaceuticals Ltd. share price target

Name: Latest research reports of SMS Pharmaceuticals Ltd. authored by Karvy and published by - Trendlyne research reports.
Item: SMS Pharmaceuticals Ltd.
Rating: 3
Author: Karvy

There are 1 reports from 1 analysts covering SMS Pharmaceuticals Ltd. available on trendlyne.com.

Reco - This broker has downgraded this stock from it's previous report.
(eg. - Buy->Hold)

Target - Broker has maintained previous recommendation but reduced share price target.

Reco - This broker has upgraded this stock from it's previous report.
(eg. - Sell->Hold)

Target - Broker has maintained previous recommendation but increased share price target.

Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report		Discuss
	04 Mar 2025	SMS Pharmaceuticals	Edelweiss	219.26		191.84 (14.29%)		Not Rated	pdf post cache		Broker Report SMS Pharmaceuticals \| Plant Visit Note Edelweiss Ibuprofen to accelerate growth pdf Copy Link Share on Share on Share on Share on Alert
	09 Jul 2015	SMS Pharmaceuticals	Karvy	219.26		60.88 (260.15%)	Pre-Bonus/ Split	Hold	pdf post cache		Broker Report SMS Pharmaceuticals Ltd: Stable Stage Post Volatility; Future Plans to Unfold (Jul 09, 2015) Karvy Scaled up base portfolio: The company has a base portfolio in long standingGastrointestinal and Antimigraine accounting for close to 40% of existing portfolio.Operating in such long standing therapies, the company delivered Rs. 5000 Mn inrevenues in FY14 (111% YoY) and sustained the scale with 12% growth in FY15. pdf Copy Link Share on Share on Share on Share on Alert

* Please note that subscribers can download a maximum of 300 reports a month and 70 reports everyday.

44.91% Fall from 52W High

SMS Pharmaceuticals Ltd. share price target

There are 1 reports from 1 analysts covering SMS Pharmaceuticals Ltd. available on trendlyne.com.

SMS Pharmaceuticals | Plant Visit Note

SMS Pharmaceuticals Ltd: Stable Stage Post Volatility; Future Plans to Unfold (Jul 09, 2015)

Advisor Screeners